13F-HR filed by Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-01-19, with 83 holding rows worth $1,225,683,000.
- Accession
- 0001213900-21-002698
- Filer
- CIK 1599882
- Filed
- 2021-01-19
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 83 entries on the cover page, a total value of $1,225,683,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,225,693,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AbbVie,Inc. | 00287Y109 | COM | 500,000 | $53,575,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 510,000 | $44,722,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 600,000 | $43,890,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 320,000 | $37,485,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 105,000 | $36,821,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 220,000 | $36,311,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 180,000 | $30,391,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 140,000 | $29,145,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 420,000 | $28,686,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 344,020 | $28,141,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 115,000 | $27,179,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 80,000 | $25,687,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 58,000 | $23,796,000 | thousands by filing date | |
| TELADOC HEALTH INC | 87918A105 | COM | 115,000 | $22,995,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 460,000 | $22,963,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,350,000 | $22,950,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 385,000 | $22,430,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 100,000 | $21,964,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 170,000 | $21,910,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 340,000 | $21,090,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 120,000 | $20,765,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 160,000 | $20,470,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 63,000 | $20,425,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 235,000 | $20,142,000 | thousands by filing date | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 55,000 | $19,983,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 40,000 | $19,324,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 530,000 | $19,054,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 120,000 | $18,749,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 115,000 | $18,099,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 285,000 | $17,109,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 205,000 | $16,449,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 150,000 | $16,424,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 500,000 | $15,900,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 270,000 | $15,444,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 592,225 | $15,398,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 320,000 | $14,848,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 111,700 | $14,518,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 150,000 | $14,378,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 625,000 | $14,288,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 821,888 | $12,826,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 27,450 | $12,786,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 190,000 | $12,580,000 | thousands by filing date | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 250,000 | $12,513,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 75,000 | $12,335,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 850,000 | $11,484,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 125,000 | $11,404,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 65,000 | $11,384,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 259,341 | $11,315,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 45,000 | $11,260,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 65,000 | $10,016,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 75,000 | $9,937,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 40,000 | $9,794,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 125,000 | $9,408,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 481,826 | $8,605,000 | thousands by filing date | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 125,000 | $7,873,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 450,000 | $6,813,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 625,000 | $6,775,000 | thousands by filing date | |
| ACCOLADE INC | 00437E102 | COM | 150,000 | $6,525,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 220,000 | $6,235,000 | thousands by filing date | |
| SHOCKWAVE MED INC | 82489T104 | COM | 60,000 | $6,223,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,736,176 | $6,077,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 175,000 | $5,814,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 7,000 | $5,727,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 130,000 | $5,633,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 200,000 | $5,524,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 70,000 | $5,378,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 145,000 | $5,378,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 240,000 | $4,318,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 250,000 | $4,253,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 209,354 | $4,177,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 925,534 | $4,119,000 | thousands by filing date | |
| OAK STR HEALTH INC | 67181A107 | COM | 60,000 | $3,670,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 60,000 | $3,424,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 130,000 | $3,254,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 775,000 | $2,961,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 265,000 | $2,878,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 564,400 | $2,873,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 156,700 | $1,869,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 125,000 | $1,729,000 | thousands by filing date | |
| AMERICAN WELL CORP | 03044L105 | CL A | 60,000 | $1,520,000 | thousands by filing date | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 35,000 | $1,412,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 300,000 | $966,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 300,000 | $750,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-21-002698 | this filing | 2021-01-19 | acceptance time not in the bulk data set |